AdvisorShares Investments LLC
Position in KTTA — Pasithea Therapeutics Corp.
CIK 1425930
BETHESDA, MD
Position in KTTA
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$250,430
-$142,660 QoQ
Shares Held
337,508
+10.8% QoQ
Ownership
1.01%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KTTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AdvisorShares Investments LLC holds $17,592,416 across 20 Biotechnology names. KTTA ranks #16 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RLMD |
Relmada Therapeutics, Inc.
|
295,872 | $2,059,269 | |
| 2 | ATAI |
AtaiBeckley Inc.
|
567,587 | $2,009,257 | |
| 3 | DFTX |
Definium Therapeutics, Inc.
|
91,301 | $1,725,588 | |
| 4 | ASND |
Ascendis Pharma A/S
|
5,750 | $1,315,197 | |
| 5 | ABVX |
Abivax S.A.
|
11,802 | $1,314,152 | |
| 6 | DBVT |
DBV Technologies S.A.
|
50,340 | $1,051,602 | |
| 7 | GHRS |
GH Research PLC
|
67,034 | $942,498 | |
| 8 | HELP |
Cybin Inc.
|
195,604 | $938,899 |
All Filings in KTTA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $250,430 | 337,508 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $393,090 | 304,721 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $188,633 | 257,696 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $139,547 | 193,547 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $69,611 | 53,547 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||